This Article Full Text Full Text (PDF) All Versions of this Article: 30/1/46    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Wu, X. Articles by Meyers-Wallen, V. N. PubMed PubMed Citation Articles by Wu, X. Articles by Meyers-Wallen, V. N.

A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Müllerian Duct Syndrome

SHASHIKANT PUJAR

MARK E. HASKINS

DONALD H. SCHLAFER

VICKI N. MEYERS-WALLEN^,

From the ^* Pediatric Endocrine Division, Department of Pediatrics and Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts; the Baker Institute for Animal Health and the Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York; and the Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Correspondence to: Vicki N. Meyers-Wallen, Baker Institute for Animal Health, Hungerford Hill Road, Cornell University, Ithaca, NY 14853 (e-mail: vnm1{at}cornell.edu).

Müllerian inhibiting substance (MIS), a secreted glycoprotein in the transforming growth factor–beta family of growth factors, mediates regression of the Müllerian ducts during embryonic sex differentiation in males. In persistent Müllerian duct syndrome (PMDS), rather than undergoing involution, the Müllerian ducts persist in males, giving rise to the uterus, fallopian tubes, and upper vagina. Genetic defects in MIS or its receptor (MISRII) have been identified in patients with PMDS. The phenotype in the canine model of PMDS derived from the miniature schnauzer breed is strikingly similar to that of human patients. In this model, PMDS is inherited as a sex-limited autosomal recessive trait. Previous studies indicated that a defect in the MIS receptor or its downstream signaling pathway was likely to be causative of the canine syndrome. In this study, the canine PMDS phenotype and clinical sequelae are described in detail. Affected and unaffected members of this pedigree are genotyped, identifying a single base pair substitution in MISRII that introduces a stop codon in exon 3. The homozygous mutation terminates translation at 80 amino acids, eliminating much of the extracellular domain and the entire transmembrane and intracellular signaling domains. Findings in this model could enable insights to be garnered from correlation of detailed clinical descriptions with molecular defects, which are not otherwise possible in the human syndrome.

     Key words: Dog, anti-Müllerian hormone, AMH type II receptor (AMHR2), Müllerian duct regression